01 dugan influenza 508

CDC ACIP — Vaccine Advisory Committee

Acip

Slides

2

Document text

U.S. Centers for Disease Control and Prevention
National Center for Immunization and Respiratory Diseases
Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation 
use. No rights are implied or extended for use in printing or any use by other CDC CIOs or any external audiences.
Influenza Session —Introduction
Dr. Vivien Dugan
Influenza Division, CDC/NCIRD
June 26, 2025
Flublok (recombinant influenza vaccine) in older children and 
adolescents: immunogenicity and safety
–Dr. Pedro Folegatti (Sanofi Pasteur)
Estimates of influenza burden and burden averted through vaccination
–Dr. Vivien Dugan (CDC/NCIRD)
2024 -25 influenza season update and seasonal influenza vaccine 
recommendations for the 2025 -26 U.S. influenza season
–Dr. Vivien Dugan (CDC/NCIRD)Session Overview
2